http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-104490857-B
Outgoing Links
| Predicate | Object |
|---|---|
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-105 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-255 |
| filingDate | 2014-11-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2018-04-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2018-04-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-104490857-B |
| titleOfInvention | Allicin parenteral solution is as the application for preparing treatment myocardial infarction disease medicament |
| abstract | The present invention relates to the applied technical field of allicin, is a kind of application of allicin parenteral solution as preparation treatment myocardial infarction disease medicament.The present invention passes through " allicin parenteral solution " intravenous, carry out histopathology, compare the myocardial infarct size of " allicin intravenous injection administration group " and model group, test result indicates that allicin parenteral solution has the drug effect of anti-infarction, illustrate that allicin parenteral solution can effectively prevent myocardial infarction disease, further illustrate that allicin parenteral solution can become a kind of new pharmaceutical formulation of efficiently treatment myocardial infarction disease. |
| priorityDate | 2014-11-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 63.